中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2014年
12期
115-117,133
,共4页
钟东海%蒋建平%范文锋%陈莉莉%莫志仙%李智睿
鐘東海%蔣建平%範文鋒%陳莉莉%莫誌仙%李智睿
종동해%장건평%범문봉%진리리%막지선%리지예
多模式镇痛%胸科手术%自控镇痛
多模式鎮痛%胸科手術%自控鎮痛
다모식진통%흉과수술%자공진통
Multimodal analgesia%Thoracic surgery%Patient-controlled analgesia
目的:对多模式镇痛对于胸科手术术后镇痛效果和不良反应进行观察,以期找到更为安全有效的胸科手术术后镇痛方式。方法将60例择期接受胸科手术的患者随机分为实验组和对照组,每组30例,实验组患者在关胸前由手术者使用罗哌卡因进行肋间神经的阻滞,在手术结束之前30min静脉注射帕瑞昔布钠,并于手术结束时给予舒芬太尼以自控镇痛;对照组在手术结束时给予舒芬太尼以自控镇痛。于患者经静脉给药自控镇痛(PCIA)开始后第2、4、6、8、12、24、48、72h对镇静(Ramsay评分)和镇痛(VAS评分)效果观察记录,同时对不良反应发生情况进行观察。结果相较于对照组,实验组患者PCA有效按压次数、舒芬太尼用量、舒适状态评分、静止和活动状态下VAS评分明显下降,对照组PCA按压次数较实验组上升(P<0.05);两组患者在术后胸闷、皮肤瘙痒、恶心呕吐、排气时间、镇静评分、生命体征等副作用发生率均没有显著差异(P>0.05)。结论多模式镇痛对于胸科手术术后镇痛效果良好,有临床推广价值。
目的:對多模式鎮痛對于胸科手術術後鎮痛效果和不良反應進行觀察,以期找到更為安全有效的胸科手術術後鎮痛方式。方法將60例擇期接受胸科手術的患者隨機分為實驗組和對照組,每組30例,實驗組患者在關胸前由手術者使用囉哌卡因進行肋間神經的阻滯,在手術結束之前30min靜脈註射帕瑞昔佈鈉,併于手術結束時給予舒芬太尼以自控鎮痛;對照組在手術結束時給予舒芬太尼以自控鎮痛。于患者經靜脈給藥自控鎮痛(PCIA)開始後第2、4、6、8、12、24、48、72h對鎮靜(Ramsay評分)和鎮痛(VAS評分)效果觀察記錄,同時對不良反應髮生情況進行觀察。結果相較于對照組,實驗組患者PCA有效按壓次數、舒芬太尼用量、舒適狀態評分、靜止和活動狀態下VAS評分明顯下降,對照組PCA按壓次數較實驗組上升(P<0.05);兩組患者在術後胸悶、皮膚瘙癢、噁心嘔吐、排氣時間、鎮靜評分、生命體徵等副作用髮生率均沒有顯著差異(P>0.05)。結論多模式鎮痛對于胸科手術術後鎮痛效果良好,有臨床推廣價值。
목적:대다모식진통대우흉과수술술후진통효과화불량반응진행관찰,이기조도경위안전유효적흉과수술술후진통방식。방법장60례택기접수흉과수술적환자수궤분위실험조화대조조,매조30례,실험조환자재관흉전유수술자사용라고잡인진행륵간신경적조체,재수술결속지전30min정맥주사파서석포납,병우수술결속시급여서분태니이자공진통;대조조재수술결속시급여서분태니이자공진통。우환자경정맥급약자공진통(PCIA)개시후제2、4、6、8、12、24、48、72h대진정(Ramsay평분)화진통(VAS평분)효과관찰기록,동시대불량반응발생정황진행관찰。결과상교우대조조,실험조환자PCA유효안압차수、서분태니용량、서괄상태평분、정지화활동상태하VAS평분명현하강,대조조PCA안압차수교실험조상승(P<0.05);량조환자재술후흉민、피부소양、악심구토、배기시간、진정평분、생명체정등부작용발생솔균몰유현저차이(P>0.05)。결론다모식진통대우흉과수술술후진통효과량호,유림상추엄개치。
Objective To observe the analgesic effect of multimodal analgesia after thoracic surgery and related adverse events, so as to find a safe and effective analgesic method after thoracic surgery. Methods 60 patients receiving selective thoracic surgery were randomly allocated to an experimental group and a control group, with 30 patients in each group. The surgeon used ropivacaine to block the intercostal nerve before sternal closure for patients in the experimental group. Patients were intravenously administered parecoxib sodium in 30 min before the end of the surgery, and were then given sufentanil for patient-controlled analgesia at the end of the surgery; patients in the control group were given sufentanil for patient-controlled analgesia at the end of the surgery. From the beginning of intravenously administered patient-controlled analgesia (PCIA), the effects of sedation (Ramsay scores) and analgesia (VAS scores) in 2, 4, 6, 8, 12, 24, 48, 72 h were observed and recorded, and the adverse events were observed simultaneously. Results Compared with the control group, effective pressing times of PCA, dosage of sufentanil, Bruggrmann comfort scale, VAS scores under calmness and activity in the experimental group significantly reduced, and the pressing times of PCA in the control group increased compared to those in experimental group (P < 0.05);incidences of chest disorder, pruritus, nausea and vomit, time of passage of gas, Ramsay scores and vital signs in the two groups after the surgery were not significantly different (P > 0.05). Conclusion Multimodal analgesia has a favourable analgesic effect for thoracic surgery, which is worthy of clinical promotion.